| 11/03/2026 3:12 PM | Brown Adrienne S (2096888) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 3:12 PM | Custer Kenneth L. (2071542) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 1:55 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/29/2026 10:35 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/29/2026 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2026 8:37 PM | Eli Lilly and Company (59478) Reporting Lycia Therapeutics, Inc. (1806540) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/20/2026 3:32 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:34 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:35 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:36 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/19/2026 2:09 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for LLY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/16/2026 3:19 PM | Eli Lilly and Company (59478) Filed by TRex Bio, Inc. (2139097) Subject | Form SCHEDULE 13D | |
| 10/15/2026 1:44 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/08/2026 8:39 PM | Eli Lilly and Company (59478) Reporting TRex Bio, Inc. (2139097) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/07/2026 2:24 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/22/2026 3:11 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:12 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:14 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:15 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:16 PM | Eli Lilly and Company (59478) Issuer Seymour Melissa (2032089) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 3:17 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 3:18 PM | Eli Lilly and Company (59478) Issuer Hernandez Edgardo (1861052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 3:22 PM | Brown Adrienne S (2096888) Reporting Eli Lilly and Company (59478) Issuer | Form 3/A | |
| 08/18/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Jonsson Patrik (1786054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:21 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/17/2026 4:06 PM | Eli Lilly and Company (59478) Subject Jonsson Patrik (1786054) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2026 3:31 PM | Eli Lilly and Company (59478) Issuer Zakrowski Donald A (1561539) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:31 PM | Eli Lilly and Company (59478) Subject Zakrowski Donald A (1561539) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Hakim Anat (1685556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 9:30 AM | Eli Lilly and Company (59478) Subject Hakim Anat (1685556) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/05/2026 1:40 PM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 6:05 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/03/2026 3:42 PM | Eli Lilly and Company (59478) Issuer Seymour Melissa (2032089) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 3:39 PM | Eli Lilly and Company (59478) Filed by Scribe Therapeutics, Inc. (1853921) Subject | Form SCHEDULE 13D | |
| 07/21/2026 3:37 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:39 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:39 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:40 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 12:40 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 2:26 PM | Eli Lilly and Company (59478) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
Elon Musk’s One Stock Retirement Plan (Ad) Stanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding two or three asymmetric home runs.
Analyst Jeff Brown says he has identified a new one, a single stock he calls Elon Musk's One Stock Retirement Plan. Click here to see Jeff Brown's full stock breakdown now |
| 06/16/2026 3:13 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:14 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 10:03 AM | Eli Lilly and Company (59478) Subject Yuffa Ilya (1826001) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 8:16 AM | Eli Lilly and Company (59478) Subject NEW YORK STOCK EXCHANGE LLC (876661) Filed by | Form 25-NSE | |
| 05/28/2026 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/22/2026 1:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2026 3:30 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:22 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 3:16 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 5:05 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 05/07/2026 3:41 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 4:25 PM | Eli Lilly and Company (59478) Subject | Form FWP | |
| 05/06/2026 3:35 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/06/2026 7:04 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/30/2026 10:25 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 12:18 PM | Eli Lilly and Company (59478) Subject Friends Fiduciary Corp (1696940) Filed by | Form PX14A6G | |
| 04/21/2026 3:14 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:16 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 2:25 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 03/31/2026 7:18 AM | Centessa Pharmaceuticals plc (1847903) Subject Eli Lilly and Company (59478) Filed by | Form DFAN14A | |
| 03/26/2026 5:02 PM | Eli Lilly and Company (59478) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 3:23 PM | Eli Lilly and Company (59478) Filer | Form DEFA14A | |
| 03/17/2026 3:29 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:30 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:35 PM | Eli Lilly and Company (59478) Filer | Form PRE 14A | |
| 02/19/2026 3:18 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4/A | |
| 02/12/2026 12:58 PM | Eli Lilly and Company (59478) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/11/2026 3:14 PM | Custer Kenneth L. (2071542) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:16 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hakim Anat (1685556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hernandez Edgardo (1861052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Jonsson Patrik (1786054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Montarce Lucas (1752447) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 6:05 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 8:27 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 01/21/2026 3:25 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:27 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 5:01 AM | Aktis Oncology, Inc. (2035832) Issuer Eli Lilly and Company (59478) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/15/2026 5:02 AM | Aktis Oncology, Inc. (2035832) Subject Eli Lilly and Company (59478) Filed by | Form SCHEDULE 13D | |
| 12/23/2025 11:52 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:41 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:42 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
The most dangerous moment in a financial crisis (Ad) Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971.
Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008. Watch Dr Weiss's free video warning before conditions worsen further |
| 12/16/2025 3:43 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:45 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:46 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 7:46 AM | Adverum Biotechnologies, Inc. (1501756) Subject Eli Lilly and Company (59478) Filed by | Form SC TO-T/A | |
| 12/08/2025 3:10 PM | Bertozzi Carolyn R (1698766) Reporting Eli Lilly and Company (59478) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/24/2025 2:01 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/21/2025 3:19 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/20/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |